All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
People

Experience the Latest Launches and Best Deals in Beauty & Spa...

admin
People

E-commerce Market in Middle East and North Africa to Reach $80...

admin
Pr Newswire

Vaxart Announces Preliminary Results of Annual Meeting of Stockholders

admin
Pr Newswire

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

admin
Pr Newswire

23andMe Reaches Agreement for Sale of Business to TTAM Research Institute...

admin
Pr Newswire

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

admin
Pr Newswire

KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies

admin
Pr Newswire

U.S. Postal Service Releases Dog Bite National Rankings

admin
Pr Newswire

HoSkar Night Returns to Ho Chi Minh City on July 10...

admin
People

Mexico Vegan Cosmetics Market Analysis and Investment Opportunities 2025-2030 Featuring Aora...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...